Partner Headlines - AMGN

  1. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD
  2. Credit Suisse Sees Solid Q4 For Amgen

    Benzinga
  3. Amgen Q4 earnings top views

    IBD
  4. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD
  5. Making Money With Charles Payne: 01/27/15

    FoxBusiness
  6. Amgen Beats Q4 Expectations

    Benzinga
  7. Stocks Weaken Late; Apple Jumps After Hours

    IBD
  8. Earnings Scheduled For January 27, 2015

    Benzinga
  9. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga
  10. Can CAR-T Therapy Live Up To The Biotech IPO Hype?

    IBD
  11. New Guru Jana Partners' Newest Stock Buys

    GuruFocus
  12. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD
  13. Cholesterol Drug Costs Eyed

    IBD
  14. Amgen's Decline May Be Linked To Comments Of Express Script's ...

    Benzinga
  15. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  16. Regeneron rises on drug data

    IBD
  17. Crude Awakening As Energy Squeezes Overall Q4 Profit

    IBD
  18. Regeneron Jumps On Favorable Cholesterol Drug Report

    IBD
  19. Drugs May Be Blockbusters

    IBD
  20. Weekly Review Shows Five Industries Gain In December

    IBD
  21. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD
  22. Pharmaceutical Companies Amgen and Kite Partner for Cancer Therapy

    GuruFocus
  23. Kite Pharma Gets Stock Price Increase Post Amgen Deal

    IBD
  24. UPDATE: Barclays Initiates Coverage On Amgen

    Benzinga
  25. Amgen, Kite Reach Cell Deal

    IBD
  26. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD
  27. Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, ...

    Benzinga
  28. Kite Pharma Up On Amgen Cancer Parternship

    IBD
  29. Stocks Drop 1% In Rising Volume; Visa Falls 1%

    IBD
  30. Morning Market Losers

    Benzinga
  31. Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm ...

    Benzinga
  32. Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy ...

    Benzinga
  33. Nasdaq, Russell 2000 Join New-High Party; GoPro Up Again

    IBD
  34. Tesla Motors Up On Battery News; Stocks At Record

    IBD
  35. Biotech Stocks Take A Beating, But Find Support

    IBD
  36. Are There Any Winners Left In The Biotech Space?

    Benzinga
  37. Indexes Turn Mixed On Data; Celgene Dives

    IBD
  38. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  39. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  40. Meet 5 Big Tech Stocks Expected To See Profits Surge

    IBD
  41. Amgen Just Crashed 50% In Premarket, Here's How It Looked

    Benzinga
  42. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus
  43. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD
  44. How Can Drugmakers Handle New Pricing Pressures?

    IBD
  45. Gilead Sciences Bucks Trend In Biotech Short Interest

    Benzinga
  46. 3 Biotech ETFs Rally On Merger News

    Benzinga
  47. New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec ...

    Benzinga
  48. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD
  49. Large-Blend Funds Take The Lead For Year-To-Date Total Returns

    Benzinga
  50. A Look At 3 Overbought ETFs

    Benzinga
  51. Big CEOs Are Less Upbeat, But Plan To Hire More

    IBD
  52. Endonovo Therapeutics Receives Final Commissioned Report Recommendations ...

    GuruFocus
  53. Meet 5 Top Drug Stocks That Are Bolting Past Market

    IBD
  54. AMGEN

    IBD
  55. #PreMarket Primer: Tuesday, November 25: Violent Protests In ...

    Benzinga
  56. Dividend Aristocrats In Focus Part 45: AbbVie

    GuruFocus
  57. Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies ...

    Benzinga
  58. #PreMarket Primer: Wednesday, November 19: Burst Of Cold Creates ...

    Benzinga
  59. Merck Drug Works: Vytorin Study Proves Successful

    IBD
  60. Events for the Week of Nov. 17-21, 2014

    Benzinga
  61. Amgen Shares Consolidating Ahead Of More Gains?

    Benzinga
  62. UPDATE: Deutsche Bank Reiterates On Amgen On Potential Of New ...

    Benzinga
  63. Amgen And AstraZeneca Announce Positive Results From Second Pivotal ...

    Benzinga
  64. Big Cap 20 Stuffed With Medical Names

    IBD
  65. Markets Mostly Lower As Americans Head To Vote, Oil Continues ...

    Benzinga
  66. AbbVie Beats Q3 Earnings Estimates, Raises Guidance

    IBD
  67. Ebola Vaccine Contenders

    Benzinga
  68. Stocks Trim Losses After Fed Report; Solarwinds Soars

    IBD
  69. UPDATE: Nomura Upgrades Amgen

    Benzinga
  70. Amgen resists pressure to split

    IBD
  71. Amgen: Stronger Drug Portfolio with Acquisition

    GuruFocus
  72. Amgen Refuses To Split, But Plans Hearten Investors

    IBD
  73. Amgen At All-Time High, Deutsche Bank Ups Price Target

    Benzinga
  74. Stocks Extend Gains As Alibaba, Tesla Rally

    IBD
  75. Stocks Launch In Climbing Mood; Amgen, Spirit Airlines Climbing

    IBD
  76. Amgen Rallies 3% After Announcing Growth And Capital Plans

    Benzinga
  77. Four Biotechs Lead Health Care Stocks In Big Cap 20

    IBD
  78. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD
  79. Amgen Earnings Clear Views

    IBD
  80. Amgen Beats Q3 Earnings Estimates

    Benzinga
  81. Twitter Off, Amgen, Buffalo Wild Wings Up After Hours

    IBD
  82. Dow, Nasdaq Battle Near Flat Line; Energy Weighs On S&P 500

    IBD
  83. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line ...

    Benzinga
  84. Earnings Scheduled For October 27, 2014

    Benzinga
  85. Keep an Eye on These 7 Stocks for October 27, 2014

    Benzinga
  86. Stocks Put End To Four-Week Slide

    IBD
  87. Fast Money Picks For October 23

    Benzinga
  88. Drug ETFs Attractive Buys On Pullback

    Benzinga
  89. Biotechs Show Fed Chief's Not Much Of A Stock Analyst

    IBD
  90. Daniel Loeb Comments on Amgen Inc

    GuruFocus
  91. Third Point Q3 2014 Investor Letter

    GuruFocus
  92. Markets In Rally Mode: S&P 500 And Nasdaq Surge As Dow Lags

    Benzinga
  93. Third Point's Notable Additions And Exit: Alibaba, eBay, Sony

    Benzinga
  94. Stocks To Watch For October 20, 2014

    Benzinga
  95. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  96. Regeneron's Eylea Tops Rivals

    IBD
  97. Amgen Announces Appointment Of R. Sanders Williams To Board Of ...

    Benzinga
  98. Regeneron Eye Drug Beats Rivals While Amgen Sues

    IBD
  99. Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement

    Benzinga
  100. Most Top Industry Groups Fall Harder Than Market

    IBD
Trading Center